ArticlePlant molecular biology2025
Identification of DELLA and GID1 genes in Catharanthus roseus and their potential role in regulating vindoline biosynthesis.
Article in Plant molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- CmGID1A-RGL1 GA-Dependent Interaction Orchestrates Flowering in Chrysanthemum.Plants (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
DELLAs are key regulators of plant growth and development, negatively regulating gibberellic acid (GA) signaling and positively regulating light and jasmonate signaling and juvenile leaf development. In the presence of GA, GID1s bind to DELLAs and signal for their degradation. Here, we identified and characterized DELLA and GID1 genes in Catharanthus roseus, the natural source of chemotherapy drugs vinblastine and vincristine. We hypothesized that CrDELLAs positively regulate vindoline biosynthesis, a precursor of vinblastine and vincristine, accumulating in light- and jasmonate-exposed young leaves. To explore this hypothesis, we silenced CrDELLA or CrGID1 genes using virus-induced gene silencing. CrDELLA-silenced plants were elongated while CrGID1-silenced plants were dwarfed, consistent with their roles in GA-mediated growth. In the first experiment, CrDELLA-silencing significantly decreased vindoline pathway gene expression while CrGID1-silencing significantly increased vindoline, catharanthine, ajmalicine, and serpentine accumulation. However, subsequent experiments found little to no effect. C. roseus seedlings treated with paclobutrazol, an inhibitor of GA biosynthesis shown to increase DELLA protein stability, also provided some evidence for CrDELLA’s positive role in regulating vindoline pathway gene expression. Finally, overexpressed stabilized, N-terminal truncated CrDELLAs in C. roseus seedlings yielded significant increases in vindoline pathway promoter activity (NMT, D4H). Overall, these experiments provide weak to moderate evidence for CrDELLAs positively regulating vindoline biosynthesis. Future experiments with transgenic approaches could strengthen the evidence and clarify this relationship. Activation of the vindoline pathway with stabilized CrDELLAs could increase the production of critical chemotherapeutics, vinblastine and vincristine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.